Key result
Continuous-flow LVAD support only partially restores exercise capacity due to persistent peripheral oxygen uptake limitations.
Why the study?
Continuous-flow left ventricular assist devices increase forward flow but do not consistently improve VO2 max, leaving unclear how adjustable artificial forward flow impacts heart failure exercise physiology and oxygen transport.
How does axial continuous-flow left ventricular assist device support impact the exercise physiology of oxygen transport and uptake in patients with advanced heart failure?
How does axial continuous-flow left ventricular assist device support impact the exercise physiology of oxygen transport and uptake in patients with advanced heart failure?
This review highlights the complex impact of continuous-flow LVAD support on exercise physiology and oxygen transport in advanced heart failure, explaining why it may not consistently improve VO2 max.
CF-LVAD support may incompletely restore exercise capacity in advanced HF; leaves open peripheral-targeted strategies to optimize oxygen uptake.
Low-output forward flow and impaired maximal exercise oxygen uptake (VO2 max) are hallmarks of patients in advanced heart failure. The continuous-flow left ventricular assist device is a cutting-edge therapy proven to increase forward flow, yet this therapy does not yield consistent improvements in VO2 max. The science of how adjustable artificial forward flow impacts the exercise physiology of heart failure and physical O2 transport between the central and peripheral systems is unclear. This review focuses on the exercise physiology of axial continuous-flow left ventricular assist device support and the impact that pump speed has on the interactive convective and diffusive components of whole-body physical O2 transport and VO2.
No takes yet. Share an insight, caveat, or question.
Erik H. Van Iterson (2019) conducted a review in Advanced heart failure. Continuous-flow left ventricular assist device (cf-LVAD) support and pump speed adjustment was evaluated. Continuous-flow left ventricular assist device support only partially restores aerobic exercise capacity, as increased artificial forward flow does not unilaterally overcome peripheral limitations in whole-body oxygen transport and uptake.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: